Eli Lilly

News

A sad young woman is sitting in her kitchen with a headache

Lilly joins CGRP race to cure migraine

Eli Lilly are gearing up to announce details from the latest Emgality analysis, which can potentially push the biotech to the leading pack of the migraine cure race, among Allergan, Amgen a

News

AstraZeneca and Lilly’s Alzheimer’s drug fails trial

The battle to develop a drug to treat Alzheimer’s disease has been dealt a blow following disappointing phase 3 trial results.

News

Lilly drug scrapes through cluster headache trial

FDA to make decision on Amgen drug tomorrow

News

Lilly buys cancer biotech ARMO for $1.6bn

Lilly adds pancreatic cancer drug to pipeline

News

Lilly and Alder showcase latest migraine drug data

Lilly and Alder take on the might of Novartis and Amgen

News

Novartis/Amgen migraine jab works in tough-to-treat patients

Novartis continues to build the case for its Aimovig migraine injection,with data showing it works in a tough-to-treat patient group.

Lilly joins CGRP race to cure migraine

AstraZeneca and Lilly’s Alzheimer’s drug fails trial

Lilly drug scrapes through cluster headache trial

Lilly buys cancer biotech ARMO for $1.6bn

Lilly and Alder showcase latest migraine drug data

Novartis/Amgen migraine jab works in tough-to-treat patients

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

Eli Lilly

Editor's Picks